Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review

Thalassemias are a group of inherited blood disorders that affects 5–7% of the world population. Comprehensive screening strategies are essential for the management and prevention of this disorder. Today, many clinical and research laboratories have widely utilized next-generation sequencing (NGS) t...

Full description

Bibliographic Details
Main Authors: Syahirah Amnani Suhaimi, Ihsan Nazurah Zulkipli, Hazim Ghani, Mas Rina Wati Abdul-Hamid
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1015769/full
_version_ 1811258008721686528
author Syahirah Amnani Suhaimi
Ihsan Nazurah Zulkipli
Hazim Ghani
Mas Rina Wati Abdul-Hamid
author_facet Syahirah Amnani Suhaimi
Ihsan Nazurah Zulkipli
Hazim Ghani
Mas Rina Wati Abdul-Hamid
author_sort Syahirah Amnani Suhaimi
collection DOAJ
description Thalassemias are a group of inherited blood disorders that affects 5–7% of the world population. Comprehensive screening strategies are essential for the management and prevention of this disorder. Today, many clinical and research laboratories have widely utilized next-generation sequencing (NGS) technologies to identify diseases, from germline and somatic disorders to infectious diseases. Yet, NGS application in thalassemia is limited and has just recently surfaced due to current demands in seeking alternative DNA screening tools that are more efficient, versatile, and cost-effective. This review aims to understand the several aspects of NGS technology, including its most current and expanding uses, advantages, and limitations, along with the issues and solutions related to its integration into routine screening and diagnosis of thalassemias. Hitherto, NGS has been a groundbreaking technology that offers tremendous improvements as a diagnostic tool for thalassemia in terms of its higher throughput, accuracy, and adaptability. The superiority of NGS in detecting rare variants, solving complex hematological problems, and providing non-invasive alternatives to neonatal diagnosis cannot be overlooked. However, several pitfalls still preclude its use as a stand-alone technique over conventional methods.
first_indexed 2024-04-12T18:06:31Z
format Article
id doaj.art-ab44b8ac3a07442fa453e6d103693234
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-12T18:06:31Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-ab44b8ac3a07442fa453e6d1036932342022-12-22T03:21:58ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-09-011010.3389/fped.2022.10157691015769Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-reviewSyahirah Amnani SuhaimiIhsan Nazurah ZulkipliHazim GhaniMas Rina Wati Abdul-HamidThalassemias are a group of inherited blood disorders that affects 5–7% of the world population. Comprehensive screening strategies are essential for the management and prevention of this disorder. Today, many clinical and research laboratories have widely utilized next-generation sequencing (NGS) technologies to identify diseases, from germline and somatic disorders to infectious diseases. Yet, NGS application in thalassemia is limited and has just recently surfaced due to current demands in seeking alternative DNA screening tools that are more efficient, versatile, and cost-effective. This review aims to understand the several aspects of NGS technology, including its most current and expanding uses, advantages, and limitations, along with the issues and solutions related to its integration into routine screening and diagnosis of thalassemias. Hitherto, NGS has been a groundbreaking technology that offers tremendous improvements as a diagnostic tool for thalassemia in terms of its higher throughput, accuracy, and adaptability. The superiority of NGS in detecting rare variants, solving complex hematological problems, and providing non-invasive alternatives to neonatal diagnosis cannot be overlooked. However, several pitfalls still preclude its use as a stand-alone technique over conventional methods.https://www.frontiersin.org/articles/10.3389/fped.2022.1015769/fullNGStargeted sequencingWESWGSα-thalassemiaβ-thalassemia
spellingShingle Syahirah Amnani Suhaimi
Ihsan Nazurah Zulkipli
Hazim Ghani
Mas Rina Wati Abdul-Hamid
Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
Frontiers in Pediatrics
NGS
targeted sequencing
WES
WGS
α-thalassemia
β-thalassemia
title Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
title_full Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
title_fullStr Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
title_full_unstemmed Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
title_short Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review
title_sort applications of next generation sequencing in the screening and diagnosis of thalassemia a mini review
topic NGS
targeted sequencing
WES
WGS
α-thalassemia
β-thalassemia
url https://www.frontiersin.org/articles/10.3389/fped.2022.1015769/full
work_keys_str_mv AT syahirahamnanisuhaimi applicationsofnextgenerationsequencinginthescreeninganddiagnosisofthalassemiaaminireview
AT ihsannazurahzulkipli applicationsofnextgenerationsequencinginthescreeninganddiagnosisofthalassemiaaminireview
AT hazimghani applicationsofnextgenerationsequencinginthescreeninganddiagnosisofthalassemiaaminireview
AT masrinawatiabdulhamid applicationsofnextgenerationsequencinginthescreeninganddiagnosisofthalassemiaaminireview